Cardiol Therapeutics (CRDL) Beginning Cash Balance (2021 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Beginning Cash Balance came in at $15.6 million in Q1 2026, down 26.72% YoY from $21.3 million in Q1 2025, and down 26.72% on a QoQ basis from $21.3 million in Q1 2025.
Cardiol Therapeutics (CRDL) Beginning Cash Balance (2021 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 6 years of Beginning Cash Balance data on file, last reported at $15.6 million in Q1 2026.
- Quarterly Beginning Cash Balance fell 26.72% year-over-year to $15.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.9 million (down 21.82% YoY) and the FY2021 annual result came in at $11.2 million, up 115.52% from the prior year.
- Beginning Cash Balance retreated to $15.6 million in Q1 2026, from $21.3 million in the prior quarter.
- In the past five years, Beginning Cash Balance ranged from a high of $66.2 million in Q1 2022 to a low of $15.6 million in Q1 2026.
- A 5-year average of $34.6 million and a median of $25.9 million in 2024 frame the typical range for Beginning Cash Balance.
- Annual changes were most pronounced in 2022 — Beginning Cash Balance jumped 497.73% — and 2024, when it sank 41.07%.
- Tracing CRDL's Beginning Cash Balance over 5 years: stood at $66.2 million in 2022, then tumbled by 33.59% to $44.0 million in 2023, then slumped by 41.07% to $25.9 million in 2024, then declined by 17.79% to $21.3 million in 2025, then declined by 26.72% to $15.6 million in 2026.
- The last three Beginning Cash Balance figures came in at $15.6 million (Q1 2026), $21.3 million (Q1 2025), and $25.9 million (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.62 Mn |
| Mar 31, 2026 | 15.62 Mn |
| Mar 31, 2025 | 21.31 Mn |
| Mar 31, 2025 | 21.31 Mn |
| Mar 31, 2024 | 25.92 Mn |
| Mar 31, 2024 | 25.92 Mn |
| Mar 31, 2023 | 43.99 Mn |
| Mar 31, 2023 | 43.99 Mn |
| Mar 31, 2022 | 66.24 Mn |
| Mar 31, 2022 | 66.24 Mn |
| Mar 31, 2021 | 11.08 Mn |
| Mar 31, 2021 | 11.08 Mn |